The largest database of trusted experimental protocols

7 protocols using pe anti mouse human cd11b

1

Multiparametric Flow Cytometry for Tumor Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For blood and tumor samples from mice, the following antibodies were purchased from BioLegend: anti-human CD45-APC (BioLegend Cat# 304011, RRID:AB_314399), anti-human CD45-Brilliant Violet 421™ (BioLegend Cat# 304032, RRID:AB_2561357), anti-human CD4-APC (BioLegend Cat# 300514, RRID:AB_314082), anti-human CD4-PE/Cyanine7 (BioLegend Cat# 300512, RRID:AB_314080), anti-human CD8-FITC (BioLegend Cat# 980908, RRID:AB_2888883), anti-human CD8-Brilliant Violet785™ (BioLegend Cat# 344739, RRID:AB_2566201), anti-mouse CD45-APC (BioLegend Cat# 103111, RRID:AB_312976), anti-mouse CD45-Brilliant Violet 711™ (BioLegend Cat# 103147, RRID:AB_2564383), anti-mouse/human CD11b-Brilliant Violet 570™ (BioLegend Cat# 101233, RRID:AB_10896949), anti-mouse/human CD11b-PE (BioLegend Cat# 101208, RRID:AB_312791), anti-mouse/human CD11b-PE/Cyanine7 (BioLegend Cat# 101215, RRID:AB_312798), anti-mouse Ly6G-FITC (BioLegend Cat# 127606, RRID:AB_1236494), anti-mouse Ly6G-PerCP/Cyanine5.5 (BioLegend Cat# 127616, RRID:AB_1877271), anti-mouse Ly-6C-PerCP/Cyanine5.5 (BioLegend Cat# 128012, RRID:AB_1659241), anti-mouse F4/80-PE/Cyanine7 (BioLegend Cat# 123114, RRID:AB_893478), anti-mouse F4/80-PE (BioLegend Cat# 123110, RRID:AB_893486).
+ Open protocol
+ Expand
2

Murine Immune Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were prepared from the spleens and peripheral blood of mice. Spleens were mechanically disrupted using the plunger end of a 10 ml syringe and resuspended in 1% FBS/PBS. Peripheral blood in centrifuge tubes was placed into a 4℃ high speed centrifuge and spun at 1500 rpm for 5 min. The supernatant was frozen at -20℃ for subsequent ELISA detection. Then, 2 ml of erythrocyte lysate was added to the precipitate of the centrifuge tube, vibrated and incubated at room temperature for 10 min. Then, the tubes were centrifuged, the supernatant was discarded, and the cells were resuspended in 1% FBS/PBS.
Zombie NIR Fixable Viability Kit (Biolegend, USA) were used to stain dead cells. For cell-surface markers, single-cell suspensions were harvested and incubated with anti-mouse/human CD11b-PE, anti-mouse Ly-6G/Ly-6C (Gr-1)-APC, anti-mouse CD4-FITC, anti-mouse CD8a-PE, anti-mouse CD25-APC, anti-mouse FOXP3-PE or appropriate isotype controls (Biolegend, USA) for 30 min at 4 °C. Fixation buffer was added for 20 min, then cells were resuspended in 1% PBS. Finally, all samples were analysed by flow cytometry, and data analysis was processed using FlowJo V10 (Treestar, Inc.).
+ Open protocol
+ Expand
3

Comprehensive Immune Profiling of Murine Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Carprofen (Rimadyl® Injectable, 50 mg/mL) was purchased from Patterson Companies (Saint Paul, MN, USA). Pacific Blue™ anti-mouse CD3, FITC anti-mouse CD4, PerCP anti-mouse CD8a, PE anti-mouse/human CD11b, APC/Cy7 anti-mouse Ly-6G/Ly-6C (Gr-1), PE/Cy7 anti-mouse CD62L, APC anti-mouse/human CD44, APC anti-mouse CD25, Biolegend PE anti-mouse/rat/human FOXP3, PerCP anti-mouse CD11c, PE/Cy7 anti-mouse CD86, FITC anti-mouse I-A/I-E, and APC anti-mouse CD40 were purchased from Biolegend (San Diego, CA, USA). Mouse tumor dissociation kit (No. 130-096-730) was purchased from Miltenyi Biotec (Bergisch Gladbach, Germany).
+ Open protocol
+ Expand
4

Multicolor Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Lymphatic endothelial cell and monocyte/macrophage staining, cells were stained for PE anti-mouse/human CD11b (Biolegend, #101208), Pacific Blue™ anti-mouse CD45 (Biolegend, #103126), APC anti-mouse F4/80 (Biolegend, #123116), Lyve-1 (Abcam, #ab14917), Ly6C-PE (Thermo Fisher, #12593282), Alexa Fluor™ 488 goat anti-rabbit IgG (Thermo Fisher Scientific, #A11034). Data were recorded with an LSR II flow cytometer (BD Biosciences) and analyzed with FlowJo (Version 9.0).
+ Open protocol
+ Expand
5

Comprehensive Immune Cell Profiling in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
After blocking with 2% rat serum, cells were stained for APC-Cy7 rat anti-mouse CD45 (BD), BV421 hamster anti-mouse CD11c (BD), PerCP-Cy5.5 rat anti-mouse I-A/I-E (BD), PE-Cy7 rat anti-mouse Ly-6C (BD), BV510 rat anti-mouse Ly-6G (BD), APC rat anti-mouse F4/80 (BD), PE anti-mouse/human CD11b (Biolegend), and Fixable Viability Stain 700 (BD). The stained cells were analyzed using BD FACS Canto II and DIVA software.
+ Open protocol
+ Expand
6

PMA-Induced Monocyte Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP-1 cells were treated with phorbol 12-myristate 13-acetate (PMA, 100 ng/mL; P1585, Sigma, USA) for 48 h. CD14 monoclonal antibody (APC) (17-0149-41, eBioscience, USA) or PE anti-mouse/human CD11b (101207, BioLegend, USA) fluorescent antibody was added to the cell suspension and incubated for 30 min away from light. The proportions of CD14- and CD11b-positive cells were detected via flow cytometry (CytoFLEX, Beckman, USA).
+ Open protocol
+ Expand
7

Macrophage Depletion Attenuates CIPN

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liposomal clodronate at 1.05 mg/mouse was administered i.p. on days 5 and 7 of bortezomib treatment, and nociceptive threshold was measured daily until day 8. To confirm the successful macrophage depletion, the spleen was isolated from the mice that were sacrificed by cervical dislocation following the measurement of nociceptive threshold on day 8 after the onset of bortezomib treatment and subjected to detection of macrophages by flow cytometry using FITC anti-mouse F4/80 (1:100; Biolegend, Inc., San Diego, CA, USA) and PE anti-mouse/human CD11b (1:200; Biolegend, Inc.), as described previously [23 (link)]. To check the effect of macrophage depletion on the established CIPN after bortezomib treatment, the mice received a single i.p. administration of liposomal clodronate at 1.05 mg/mouse on day 13 after the onset of i.p. bortezomib.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!